Literature DB >> 20974829

Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis.

Xuqing Zhang1, Sara E Hester, Mary J Kennett, Alexia T Karanikas, Liron Bendor, David E Place, Eric T Harvill.   

Abstract

Interleukin-1 receptor-deficient (IL-1R(-/-)) mice are healthy despite being colonized by commensal microbes but are defective in defenses against specific pathogens, suggesting that IL-1R-mediated effects contribute to immune responses against specific pathogenic mechanisms. To better define the role of IL-1R in immunity to respiratory infections, we challenged IL-1R(-/-) mice with Bordetella pertussis and Bordetella parapertussis, the causative agents of whooping cough. Following inoculation with B. pertussis, but not B. parapertussis, IL-1R(-/-) mice showed elevated bacterial numbers and more extensive inflammatory pathology than wild-type mice. Acellular B. pertussis vaccines were not efficiently protective against B. pertussis in IL-1R(-/-) mice. B. pertussis-stimulated dendritic cells from IL-1R(-/-) mice produced higher levels of tumor necrosis factor alpha (TNF-α) and IL-6 than wild-type cells. Moreover, elevated levels of gamma interferon (IFN-γ) and TNF-α but lower levels of IL-10 were detected during B. pertussis infection in IL-1R(-/-) mice. Since B. parapertussis did not cause severe disease in IL-1R(-/-) mice, we hypothesized that the extreme requirement for IL-1R involves pertussis toxin (Ptx), which is expressed only by B. pertussis. An isogenic Ptx-deficient B. pertussis strain had only a modest phenotype in wild-type mice but was completely defective in causing lethal disease in IL-1R(-/-) mice, indicating that the particular virulence of B. pertussis in these mice requires Ptx. Ptx contributes to IL-1β induction by B. pertussis, which is involved in IL-10 induction through IL-1R signaling. IL-10 treatment reduced B. pertussis numbers in IL-1R(-/-) mice, suggesting that the lower IL-10 responses partially account for the uncontrolled inflammation and bacterial growth in these mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20974829      PMCID: PMC3019879          DOI: 10.1128/IAI.00590-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  79 in total

1.  Use of pertussis toxin encoded by ptx genes from Bordetella bronchiseptica to model the effects of antigenic drift of pertussis toxin on antibody neutralization.

Authors:  S Z Hausman; D L Burns
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

2.  Subcellular localization and immunological detection of proteins encoded by the vir locus of Bordetella pertussis.

Authors:  S Stibitz; M S Yang
Journal:  J Bacteriol       Date:  1991-07       Impact factor: 3.490

3.  TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells.

Authors:  Sarah C Higgins; Andrew G Jarnicki; Ed C Lavelle; Kingston H G Mills
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

4.  Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine.

Authors:  Paul Mann; Elizabeth Goebel; James Barbarich; Mylisa Pilione; Mary Kennett; Eric Harvill
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

5.  A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.

Authors:  N A Thornberry; H G Bull; J R Calaycay; K T Chapman; A D Howard; M J Kostura; D K Miller; S M Molineaux; J R Weidner; J Aunins
Journal:  Nature       Date:  1992-04-30       Impact factor: 49.962

6.  Pertussis toxin targets airway macrophages to promote Bordetella pertussis infection of the respiratory tract.

Authors:  Nicholas H Carbonetti; Galina V Artamonova; Nico Van Rooijen; Victor I Ayala
Journal:  Infect Immun       Date:  2007-01-22       Impact factor: 3.441

7.  Interleukin 1 induces NF-kappa B through its type I but not its type II receptor in lymphocytes.

Authors:  E Stylianou; L A O'Neill; L Rawlinson; M R Edbrooke; P Woo; J Saklatvala
Journal:  J Biol Chem       Date:  1992-08-05       Impact factor: 5.157

8.  Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor.

Authors:  Nina Reiniger; Martin M Lee; Fadie T Coleman; Christopher Ray; David E Golan; Gerald B Pier
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

9.  Molecular cloning of the interleukin-1 beta converting enzyme.

Authors:  D P Cerretti; C J Kozlosky; B Mosley; N Nelson; K Van Ness; T A Greenstreet; C J March; S R Kronheim; T Druck; L A Cannizzaro
Journal:  Science       Date:  1992-04-03       Impact factor: 47.728

10.  Role of interleukin-1 in the pathogenesis of experimental shigellosis.

Authors:  P J Sansonetti; J Arondel; J M Cavaillon; M Huerre
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

View more
  14 in total

1.  Epithelial anion transporter pendrin contributes to inflammatory lung pathology in mouse models of Bordetella pertussis infection.

Authors:  Karen M Scanlon; Yael Gau; Jingsong Zhu; Ciaran Skerry; Susan M Wall; Manoocher Soleimani; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

2.  Pertussis toxin exacerbates and prolongs airway inflammatory responses during Bordetella pertussis infection.

Authors:  Carey E Connelly; Yezhou Sun; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

Review 3.  Inhibition of histone deacetylases in inflammatory bowel diseases.

Authors:  Rainer Glauben; Britta Siegmund
Journal:  Mol Med       Date:  2011-02-22       Impact factor: 6.354

4.  Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice.

Authors:  Xuqing Zhang; Tania Goel; Laura L Goodfield; Sarah J Muse; Eric T Harvill
Journal:  J Immunol       Date:  2011-03-11       Impact factor: 5.422

5.  Resident microbiota affect Bordetella pertussis infectious dose and host specificity.

Authors:  Laura S Weyrich; Heather A Feaga; Jihye Park; Sarah J Muse; Chetan Y Safi; Olivier Y Rolin; Sarah E Young; Eric T Harvill
Journal:  J Infect Dis       Date:  2013-11-13       Impact factor: 5.226

6.  Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model.

Authors:  Jason M Warfel; Lindsey I Zimmerman; Tod J Merkel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

Review 7.  Review of the neutrophil response to Bordetella pertussis infection.

Authors:  Joshua C Eby; Casandra L Hoffman; Laura A Gonyar; Erik L Hewlett
Journal:  Pathog Dis       Date:  2015-10-02       Impact factor: 3.951

8.  A Type VI secretion system encoding locus is required for Bordetella bronchiseptica immunomodulation and persistence in vivo.

Authors:  Laura S Weyrich; Olivier Y Rolin; Sarah J Muse; Jihye Park; Nicholas Spidale; Mary J Kennett; Sara E Hester; Chun Chen; Edward G Dudley; Eric T Harvill
Journal:  PLoS One       Date:  2012-10-12       Impact factor: 3.240

9.  Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.

Authors:  Pádraig J Ross; Caroline E Sutton; Sarah Higgins; Aideen C Allen; Kevin Walsh; Alicja Misiak; Ed C Lavelle; Rachel M McLoughlin; Kingston H G Mills
Journal:  PLoS Pathog       Date:  2013-04-04       Impact factor: 6.823

10.  Toll-like receptor 4 limits transmission of Bordetella bronchiseptica.

Authors:  Olivier Rolin; Will Smallridge; Michael Henry; Laura Goodfield; David Place; Eric T Harvill
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.